Skip to main content

Bank of New York Mellon Corp

Bank

Position in APGE — Apogee Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$20,283,131
+$9,613,999 QoQ
Shares Held
152,815
+20.6% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. APGE ranks #41 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,283,131 152,815
2026-03-31 $10,669,132 126,757
2025-12-31 $8,912,976 118,084
2025-09-30 $4,272,560 107,540
2025-06-30 $8,735,983 201,151
2025-03-31 $8,003,666 214,231
2024-12-31 $5,020,461 110,827
2024-09-30 $6,614,180 112,601
2024-06-30 $5,341,642 135,747
2024-03-31 $9,121,390 137,267
2023-12-31 $1,835,181 65,683
2023-09-30 $1,270,756 59,660